History

Biopartners has an established track record of successfully developing biopharmaceuticals. With major financial backers throughout their history, in 2007 Biopartners was purchased by Bioton S.A, a dynamically-growing Polish biotechnology company. Both companies have complementary areas of expertise, enabling expansion and acceleration of product development and reducing a product’s ‘time-to-market’.

Bioton also owns SciGen Ltd, a high growth biopharmaceutical company based in Singapore that manufactures and delivers high quality, competitive healthcare products globally. The collective resources of the Bioton Group have further increased Biopartners’ access to facilities and expertise in the development, manufacturing and marketing of biopharmaceuticals, and will help speed up the delivery of both innovative biopharmaceuticals and biosimilars.


History